BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Fatty Acid Synthesis Inhibitors

Below is an extended Fatty Acid Synthesis Inhibitors research listing. Click here to return to the Fatty Acid Synthesis Inhibitors main in depth entry.

Recent Publications on Fatty Acid Synthesis Inhibitors:

A pathogenic fungi diphenyl ether phytotoxin targets plant enoyl (acyl carrier protein) reductase.
Cyperin is a natural diphenyl ether phytotoxin produced by several fungal...
Direct Link
16th September, 2008
Natural Products Utilization Research Unit, U.S. Department of
[Effect of adrenaline on the cytochrome P4502E1 content in microsomes and lysosomal fractions induced by isoniazid in rats] 9th August, 2008
Increased fatty acid synthase as a potential therapeutic target in multiple myeloma.
OBJECTIVE: To determine fatty acid synthase (FAS) expression in human...
Direct Link
19th July, 2008
Department of Hematology, the Second Affiliated Hospital, School of
cDNA microarray analysis of the expression profiles of Trichophyton rubrum in response to novel synthetic fatty acid synthase inhibitor PHS11A.
Trichophyton rubrum (T. rubrum) is a major pathogen responsible for...
Direct Link
5th June, 2008
College of Biological Sciences, China Agricultural University, Beijing
Dietary soy protein inhibits DNA damage and cell survival of colon epithelial cells through attenuated expression of fatty acid synthase.
Dietary intake of soy protein decreases tumor incidence in rat models of...
Direct Link
23rd May, 2008
Department of Physiology and Biophysics, University of Arkansas for
Selective inhibition of fatty acid synthase for lung cancer treatment.
PURPOSE: Fatty acid synthase (FAS) is overexpressed in many human cancers...
Direct Link
8th May, 2008
Department of Pathology and Johns Hopkins Cancer Center, Johns Hopkins
Pharmacological stimulation of brain carnitine palmitoyl-transferase-1 decreases food intake and body weight.
Inhibition of brain carnitine palmitoyl-transferase-1 (CPT-1) is reported...
Direct Link
28th March, 2008
Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of
The synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cells.
Liposarcomas constitute a rare group of tumors of mesenchymal origin that...
Direct Link
21st March, 2008
Department of Surgery, Section of Surgical Oncology, Norris Cotton Cancer
Comparative anticancer effects of flavonoids and diazepam in cultured cancer cells. 11th March, 2008
Nuclear Medicine, School of Medicine, Kyungpook National University,
Outer membrane permeability for nonpolar antimicrobial agents underlies extreme susceptibility of Pasteurella multocida to the hydrophobic biocide triclosan.
Pasteurella multocida exhibits nonspecific susceptibility to nonpolar...
Direct Link
16th January, 2008
Department of Biological Sciences, Mississippi State University,
Fatty acid biosynthesis as a drug target in apicomplexan parasites. 31st March, 2007
School of Botany, University of Melbourne, Melbourne, Australia.
Determination of selectivity and efficacy of fatty acid synthesis inhibitors.
Type II fatty acid synthesis (FASII) is essential to bacterial cell...
Direct Link
26th February, 2005
Department of Human and Animal Infectious Disease, Merck Research
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional